Skip to content

Clinical trials

Phase 1/2 Lymphoma, Mantle-Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 1/2 Country / region: United States Clear all

127 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20022
20034
20045
20058
20067
20075
20086
20093
20102
20117
20122
20135
20144
20153
20166
20178
20184
20196
20205
20216
20223
20233
20242
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Terminated21
Recruiting13
Active, not recruiting11
Withdrawn6
Unknown status3
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center12
M.D. Anderson Cancer Center8
National Cancer Institute (NCI)8
City of Hope Medical Center6
Mayo Clinic5
Memorial Sloan Kettering Cancer Center5
BeOne Medicines3
OHSU Knight Cancer Institute3
University of Nebraska3
AstraZeneca2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell127
Lymphoma, Follicular84
Leukemia, Lymphocytic, Chronic, B-Cell71
Lymphoma, Large B-Cell, Diffuse68
Lymphoma, Non-Hodgkin66
Lymphoma, B-Cell, Marginal Zone65
Lymphoma52
Burkitt Lymphoma43
Precursor Cell Lymphoblastic Leukemia-Lymphoma37
Hodgkin Disease36

Trials

Showing 1 to 25 of 127. Each trial links to its page on Pharma Observatory.

27 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.